Publications

Select keywords to filter the posts for matching content:

Keywords
Topics
  • Neoadjuvant and adjuvant end-points in health technology assessment in oncology.
    N. Harbeck, A. Schneeweiss, P. Thuss-Patience, K. Miller, C. Garbe, F. Griesinger, W. E. E. Eberhardt, J. P. Klussmann, B. Wollenberg, M. O. Grimm, T. Zander, D. Lüftner
    PMID: 33611103 Show Details link to full text
    Study

    AMNOG

    Year

    2021

    Keywords
    • immunotherapy
    • oncology
  • Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland
    A. Tschacher, C. Cadus, S. Schildge, J. P. Diedrich, P. N. Chhajed, A. B. Leuppi-Taegtmeyer, J. D. Leuppi
    PMID: 34433362 Show Details link to full text
    Study

    NTA Switch

    Year

    2021

    Keywords
    • Respimat inhaler
    • COPD
  • Klinisches Managment von PARP-Inhibitoren
    B. Schmalfeldt
    PMID: Show Details link to full text
    Study

    Year

    2021

    Keywords
    • PARP inhibitors
    • ovarian cancer
    • oncology
  • Optimizing therapy sequence to prevent patient attrition in EGFR mutation-positive advanced or metastatic NSCLC
    J. Roeper, S. Kurz, C. Grohé, F. Griesinger
    PMID: 33094641 Show Details link to full text
    Study

    Year

    2021

    Keywords
    • EGFR
    • NSCLC
    • tyrosine kinase inhibitor
    • oncology
  • Triplet therapy with pembrolizumab (PEM), encorafenib (ENC) and binimetinib (BIN) in advanced, BRAF V600 mutant melanoma: Final results from the dose-finding phase I part of the IMMU-Target trial
    L. Zimmer, A. Krackhardt, E. S. Schultz, D. Goeppner, C. Assaf, D. Trebing, E. Livingstone, D. Schadendorf
    PMID: Show Details link to full text
    Study

    IMMU-Target

    Year

    2021

    Keywords
    • pembrolizumab
    • encorafenib
    • binimetinib
    • oncology
    • BRAF mutation
  • A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer
    M. Hecht, D. Hahn, P. Wolber, M. G. Hautmann, D. Reichert, S. Weniger, C. Belka, T. Bergmann, T. Göhler, M. Welslau, C. Große-Thie, O. Guntinas-Lichius, J. von der Grün, P. Balermpas, K. Orlowski, D. Messinger, K. G. Stenzel, R. Fietkau
    PMID: 34298628 Show Details link to full text
    Study

    SOCCER

    Year

    2021

    Keywords
    • cetuximab
    • head and neck cancer
    • oncology
  • Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
    BEAMing, circulating tumor DNA, clonal selection, colorectal cancer, digital droplet PCR, liquid biopsy, methylation WIF1 promotor, neoRAS wild-type
    PMID: 32766143 Show Details link to full text
    Study

    RAS Convert VP

    Year

    2020

    Keywords
    • colorectal cancer
    • liquid biopsy
    • neoRAS wild-type
    • oncology
  • Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
    U. Nestle, T. Schimek-Jasch, S. Kremp, A. Schaefer-Schuler, M. Mix, A. Küsters, M. Tosch, T. Hehr, S. M. Eschmann, Y. P. Bultel, P. Hass, J. Fleckenstein, A. Thieme, M. Stockinger, K. Dieckmann, M. Miederer, G. Holl, H. C. Rischk, E. Gkika, S. Adebahr, J. König, A. L. Grosu
    PMID: 32171429 Show Details link to full text
    Study

    PET Plan

    Year

    2020

    Keywords
    • radiotherapy
    • NSCLC
    • PET/CT
    • oncology
  • Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results
    N. Teich, H. Grümmer, E. Jörgensen, T. Liceni, F. Holtkamp-Endemann, T. Fischer, S. Hohenberger
    PMID: 32550760 Show Details link to full text
    Study

    Go CUTE I

    Year

    2020

    Keywords
    • ulcerative colitis
    • QoL
    • golimumab
  • Golimumab improves patient-reported outcomes in daily practice of inflammatory rheumatic diseases in Germany
    ankylosing spondylitis, golimumab, patient-reported outcome measures, psoriatic arthritis, rheumatoid arthritis
    PMID: 32722921 Show Details link to full text
    Study

    GO-ARTeXTRA

    Year

    2020

    Keywords
    • ankylosing spondylitis
    • golimumab
    • psoriatic arthritis
    • rheumatoid arthritis
Follow:
Page: 2/5